A protein called GRB2 is found in higher levels in cells lining the skin’s blood vessels of people with systemic sclerosis (SSc) than in those of healthy individuals, meaning that GRB2 could be a potential target to treat the disease, a study suggests. Researchers observed that salvianolic acid B,…
News
People with systemic sclerosis (SSc) have a wide range of support and information needs, regardless of their disease duration, a survey found. Patients with less time since diagnosis had greater needs overall and in areas of learning how to manage their condition and how to cope psychologically and socially.
About 40% of systemic scleroderma (SSc) patients have subclinical coronary atherosclerosis (SCA), or the buildup of fatty deposits called plaques in the arteries that supply the heart without causing overt symptoms, according to a study in Italy. Data also showed that most patients who experienced a major cardiovascular event…
Aisa Pharma has launched the second part of its Phase 2a trial evaluating Profervia (cilnidipine) — an oral medication that showed positive safety and efficacy data in the study’s first part — as a treatment for Raynaud’s phenomenon in people with systemic sclerosis (SSc). Raynaud’s is…
The European Commission (EC) has given orphan drug designation to efzofitimod as a potential treatment of systemic sclerosis, also known as SSc or scleroderma, aTyr Pharma, the therapy’s developer, announced in a press release. The EC’s decision provides the company with certain incentives, such as fee reductions and…
A physiotherapy program improved sexual function and quality of life, while also preventing the deterioration in functional ability in women with systemic sclerosis (SSc), a study in the Czech Republic reports. The eight-week program consisted of a one-hour session, twice weekly, of targeted physiotherapy according to the patients’ needs.
Bloodstream levels of a protein that plays a role in the body’s response to low oxygen may be an effective biomarker to assess abnormal changes in small blood vessels associated with systemic sclerosis (SSc), according to a recent study. Levels of the protein, called hypoxia-inducible factor-1 (HIF-1), were significantly…
Plasma exchange helped reduce high blood pressure linked to scleroderma renal crisis (SRC) — a potentially life-threatening complication marked by abrupt blood pressure changes and acute kidney failure — in patients unresponsive to standard treatment, a case series study reported. Despite these successes, most patients still had impaired kidney…
Autologous hematopoietic stem cell transplant (AHSCT) helped resolve watermelon stomach in five people with systemic sclerosis (SSc), researchers in Israel report. Watermelon stomach occurs when the lining of the stomach bleeds. Having watermelon stomach, or gastric antral vascular ectasia (GAVE), could be a reason for an SSc patient to…
Blood levels of CCL24 are elevated in systemic sclerosis (SSc) patients compared to healthy people, according to a recent scientific presentation. Consistent with previous studies, higher CCL24 levels correlated with SSc severity, a threefold greater risk of interstitial lung disease (ILD) progression, and shorter five-year survival rates. “These…
Recent Posts
- Dexamethasone reduces inflammation, scarring in SSc mouse model: Study
- Survival improves for SSc-PAH patients on combination therapy
- Combination drug therapy boosts lung, skin health in SSc patients
- On choosing medicine’s side effects over scleroderma progression
- Telerehabilitation improves hand mobility in scleroderma women
- Molecular pathway ID’d as key driver of scarring in scleroderma
- Limited hand function disrupts daily life for people living with SSc
- Coping with loss is part of living with scleroderma
- CAR T-cell therapy eases SSc symptoms, early trial data show
- Milk-derived particles may offer treatment path for SSc fibrosis